ROYAL LONDON ASSET MANAGEMENT LTD
Position in RPRX — Royalty Pharma plc
CIK 863748
UNITED KINGDOM, X0
Position in RPRX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$182,686,693
+$175,743,742 QoQ
Shares Held
3,808,353
+2019.5% QoQ
Ownership
0.661%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $495,689,061 across 9 Biotechnology names. RPRX ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
3,808,353 | $182,686,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
252,192 | $112,613,815 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,610,553 | $104,090,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
215,075 | $71,161,865 | |
| 5 | INCY |
Incyte Corp
|
192,049 | $18,075,651 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,919 | $3,027,976 | |
| 7 | INSM |
INSMED Inc
|
14,498 | $2,370,712 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $1,356,750 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $182,686,693 | 3,808,353 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,942,951 | 179,683 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,296,456 | 178,471 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,430,310 | 178,471 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,651,464 | 181,544 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,532,999 | 177,695 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,531,605 | 160,184 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,110,476 | 155,877 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,312,589 | 339,565 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,039,249 | 321,796 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $8,644,469 | 318,514 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,176,532 | 265,990 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,131,536 | 142,424 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,043,581 | 127,621 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,821,961 | 120,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,212,455 | 123,988 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $4,830,572 | 123,988 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $4,705,647 | 118,084 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $4,267,555 | 118,084 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $4,840,263 | 118,084 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $5,150,824 | 118,084 | Shares | Sole | 2022-10-17 | |
| No filing history on record for this holder in this stock. | ||||||